Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
G. Starmer
Observed names:
G Starmer,
G.H Starmer,
Gregory Starmer,
Katrina Starmer,
Starmer,
Starmer, Gregory
show all 6
Institution:
Cairns Hospital
Observed institutions:
Queensland Health,
The University of Queensland,
Royal Brisbane and Women's Hospital,
Cairns Hospital,
Princess Alexandra Hospital,
James Cook University
show all 6
OpenAlex ID:
A5108961590
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019
·
Kausik K Ray
, Helen M Colhoun
, et al.
·
The Lancet Diabetes & Endocrinology
·
315
PDF
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021
·
Gregory G. Schwartz
, Gregory G. Schwartz
, et al.
·
Journal of the American College of Cardiology
·
148
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022
·
Emil Hagström
, P. Gabriel Steg
, et al.
·
Circulation
·
118
PDF
BIOSOLVE‐IV ‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients
2020
·
Stefan Verheye
, Adrian Wlodarczak
, et al.
·
Catheterization and Cardiovascular Interventions
·
74
PDF
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021
·
Gregory G. Schwartz
, Michael Szarek
, et al.
·
Diabetes Care
·
40
PDF
Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand
2020
·
S.T.H. Lo
, A.S. Yong
, et al.
·
Heart Lung and Circulation
·
28
PDF
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025
·
P. Gabriel Steg
, Michael Szarek
, et al.
·
Circulation
·
26
PDF
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024
·
Shaun G Goodman
, Philippe Gabriel Steg
, et al.
·
European Heart Journal - Cardiovascular Pharmacotherapy
·
25
PDF
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
2018
·
Jitendra PS. Sawhney
, Veerappa A. Kothiwale
, et al.
·
Indian Heart Journal
·
22
PDF
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry
2023
·
Adrian Wlodarczak
, Piero Montorsi
, et al.
·
EuroIntervention
·
20
PDF
Multimodality imaging of isolated left ventricular apical hypoplasia
2011
·
G. Starmer
, J. F. Younger
, et al.
·
European Heart Journal
·
13
PDF
The Limit of Detection in the Emergency Department Trial (LEGEND): A Stepped-Wedge Cluster Randomized Trial to Rule Out Acute Myocardial Infarction and Reduce Hospital Length of Stay for Patients Presenting to the Emergency Department
2025
·
Jaimi Greenslade
, Jaimi Greenslade
, et al.
·
Annals of Emergency Medicine
·
5
PDF
Prevalence, trends, and outcomes of same-day discharge following elective percutaneous coronary intervention: a retrospective observational cohort study using routinely collected health data
2024
·
Yingyan Chen
, Ian Smith
, et al.
·
European Journal of Cardiovascular Nursing
·
5
PDF
Developing a Same-Day Discharge Clinical Pathway for Patients Undergoing Elective Percutaneous Coronary Intervention Using a Nominal Group Technique
2025
·
Yingyan Chen
, Jacqueline Peet
, et al.
·
Heart Lung and Circulation
·
3
PDF
Clinical characteristics of Aboriginal and Torres Strait Islander emergency department patients with suspected acute coronary syndrome
2022
·
Laura Stephensen
, Jaimi Greenslade
, et al.
·
Emergency Medicine Australasia
·
3
PDF
Value of single troponin values in the emergency department for excluding acute myocardial infarction in Aboriginal and Torres Strait Islander people
2022
·
Jaimi H Greenslade
, Sara Berndt
, et al.
·
The Medical Journal of Australia
·
3
Emergency Department Assessment of Suspected Acute Coronary Syndrome Using the IMPACT Pathway in Aboriginal and Torres Strait Islander People
2022
·
Louise Cullen
, Laura Stephensen
, et al.
·
Heart Lung and Circulation
·
3
TCT-45 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris, in a Real-World Setting: First Cohort Subjects at 12-Month Follow-Up of the BIOSOLVE-IV Registry
2019
·
Stefan Verheye
, Adrian Wlodarczak
, et al.
·
Journal of the American College of Cardiology
·
3
PDF
ACS scores: risky business?
2009
·
R Lim
, G Starmer
·
Heart
·
3
Perceived barriers and facilitators to implementing a consensus-based same-day discharge post-percutaneous coronary intervention clinical pathway in Queensland, Australia
2025
·
Yingyan Chen
, Jacqueline Peet
, et al.
·
Intensive and Critical Care Nursing
·
2
TCT-81 Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting: 36-Month Outcomes of the BIOSOLVE-IV Registry
2023
·
Gregory Starmer
, Johan Bennett
, et al.
·
Journal of the American College of Cardiology
·
2
The Use of a Pulmonary Embolism Response Team (PERT) and Catheter-Directed Treatment in a Far North Queensland Regional Centre
2023
·
J. Pleash
, A. Helms
, et al.
·
Heart Lung and Circulation
·
2
PDF
Establishment of a Clinical Quality Program for Cardiac Services in Queensland Public Hospitals: The Evolution of the Queensland Cardiac Outcomes Registry (QCOR)
2023
·
W. Vollbon
, R. Poulter
, et al.
·
Heart Lung and Circulation
·
2
PDF
TCT-61 Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting—24-Month Follow-up of the Full Cohort (2,066 subjects) of the BIOSOLVE-IV Registry
2022
·
Johan Bennett
, Adrian Wlodarczak
, et al.
·
Journal of the American College of Cardiology
·
2
PDF
500.01 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real-World Setting - 12-Month Follow-Up of First 600 Subjects in Biosolve-IV Registry
2019
·
Stefano Galli
, Stefan Verheye
, et al.
·
JACC: Cardiovascular Interventions
·
2
PDF
Show more works
View as search
Works count:
51
Citation count:
498
H-index:
5
I10-index:
5
Year
Topic
Type